About Dr. Ankur Bahl

Dr. Ankur Bahl is a highly respected and leading Medical Oncologist in India, with over two decades of profound experience in clinical practice and cancer research. An alumnus of Maulana Azad Medical College and the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi, he brings a wealth of knowledge to his role. Dr. Bahl is renowned for his expertise in advanced cancer treatments, including Immunotherapy, Targeted Therapies, and modern chemotherapy protocols. His pioneering research, especially the largest Indian real-world data on Cetuximab in head and neck cancer, has significantly influenced treatment approaches nationally. Dr. Bahl is deeply committed to a patient-first philosophy, combining evidence-based medicine with compassionate care to achieve the best possible outcomes for his patients. His work in establishing innovative educational platforms further solidifies his status as a top oncologist in India.

OPD Schedule Of Dr. Ankur Bahl

Consultation Fees Rs. 1500 /-
Fortis Memorial Research Institute, Gurgaon
MON 09:00 AM - 05:00 PM
TUE 09:00 AM - 01:00 PM
WED 09:00 AM - 05:00 PM
THU 09:00 AM - 05:00 PM
FRI 09:00 AM - 01:00 PM
SAT 09:00 AM - 05:00 PM
ChatWhatsApp

Medical Degrees

  • DM (Medical Oncology) - All India Institute of Medical Sciences (AIIMS), New Delhi (2012)
  • MD (Internal Medicine) - Maulana Azad Medical College, New Delhi (2007)
  • MBBS - Maulana Azad Medical College, New Delhi (2003)

Fellowships & Special Training

  • Course on Adverse Drug Reactions, Drug Interactions and Pharmacovigilance - University of Oxford, UK
  • DNB Fellow, Department of Medical Oncology - Rajiv Gandhi Cancer Institute & Research Centre

Certifications & Accreditations

  • Member of the European Society of Medical Oncology (ESMO)
  • Member of the American Society of Clinical Oncology (ASCO)
  • Member of the Indian Society of Medical and Paediatric Oncology (ISMPO)
  • Registered with Delhi Medical Council (Reg. No.: 1854)

Major Cancer Types Treated

  • Head and Neck Cancers
  • Lung Cancer
  • Breast Cancer
  • Gastrointestinal Cancers
  • Blood Cancers (Leukaemia, Lymphoma, Multiple Myeloma)
  • Prostate Cancer
  • Cervical Cancer
  • Oral Cancer

Sub-specialties

  • Medical Oncology
  • Haemato-Oncology
  • Supportive and Palliative Care
  • Hormonal Therapy

Advanced Procedures Performed

  • Immunotherapy
  • Targeted Therapies in combination with Chemotherapy
  • Advanced Chemotherapy (Adjuvant & Neo-adjuvant)
  • PICC Line Insertion

Current & Past Hospital Affiliations

  • Senior Director - Medical Oncology, Fortis Memorial Research Institute, Gurugram (Present)
  • Director - Medical Oncology and Haematology-Oncology, Max Hospital, Saket, New Delhi
  • Consultant - Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi
  • Senior Resident, Maulana Azad Medical College, New Delhi

Academic & Research Roles

  • Lead founder of innovative oncology educational platforms and networks (International and National), including Evidence-based debates in oncology, Live Oncology Tumour boards, and Master Classes.
  • Advisor to various Biopharmaceutical Research & Development Professionals.
  • Professional Guide to international and national Medical Oncology fellows and students.

Key Achievements & Contributions

  • Authored the largest real-world Indian data on the use of Targeted Therapy (Cetuximab) in Head & Neck cancer.
  • Pioneered research in Acute Myeloid Leukaemia (AML) treatment protocols and trends of Human Papillomavirus (HPV) in the Indian population.
  • Leads several NGOs for "No Tobacco" workshops for teenagers in Delhi schools.

National & International Awards

  • Gold Medal for Best Outgoing Postgraduate Student in Medicine, Delhi University.

Published Papers in Medical Journals

  • Palliative chemotherapy with or without cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck: Indian tertiary care retrospective analysis - Head & Neck (2020).
  • He has also authored numerous other publications on topics including Acute Myeloid Leukaemia treatment and Human Papilloma Virus trends in the Indian population.

Patient Testimonials

  • "Dr. Ankur Bahl’s guidance during my husband's lung cancer treatment was a blessing. He is not only a top oncologist but also a great human being. He explained the complex treatment of immunotherapy with such clarity and was always available to address our concerns. We felt we were in the safest hands." - Mrs. Sharma
  • "I approached Dr. Bahl for a second opinion on my head and neck cancer diagnosis. His detailed assessment and confidence in the proposed targeted therapy plan gave me immense hope. I received was world-class. I highly recommend him." - Mr. Iyer
  • "Being diagnosed with leukaemia was devastating. Dr. Bahl's calm and compassionate approach made all the difference. He is incredibly knowledgeable and ensures his patients are well-informed. His expertise is the reason I am in remission today. He is truly one of the leading oncologists in India." - A. Gupta

  • Patient-Centred Care: Dr. Bahl is a firm believer in patient-centred care, focusing on creating customised treatment protocols that align with international standards. He prioritises a patient's quality of life and ensures they and their families are active partners in the decision-making process.
  • Technology & Innovation: He is at the forefront of adopting and researching the latest advancements in oncology, including Immunotherapy and Targeted Therapy. Dr. Bahl founded several educational networks to promote evidence-based debates and share the latest knowledge in oncology, showcasing his commitment to innovation.

For consultation fees, you can connect with the Cancer Rounds team.

The cost of treatment can vary based on the cancer type, stage, required therapies, and hospital choice. The table below provides an estimated cost for treatments offered by Dr. Bahl in India.

Treatment / Procedure

Estimated Cost (INR)

Estimated Cost (USD)

Chemotherapy

₹40,000 - ₹90,000 per cycle

$480 - $1,080 per cycle

Targeted Therapy

₹50,000 - ₹3,00,000 per cycle

$600 - $3,600 per cycle

Immunotherapy

₹1,50,000 - ₹4,00,000 per cycle

$1,800 - $4,800 per cycle

Head & Neck Cancer Treatment (Comprehensive)

₹3,50,000 - ₹7,00,000

$4,200 - $8,400

Leukaemia (AML/CML) Treatment

₹5,00,000 - ₹20,00,000+

$6,000 - $24,000+

Note: The costs mentioned above are estimates. The final treatment cost can differ based on individual patient requirements. For a detailed and personalised cost estimate, please connect with the Cancer Rounds team.

  • Language Support: The Cancer Rounds team provides dedicated language support and interpreters to ensure seamless communication for all international patients.
  • Visa & Travel Assistance: Our team offers comprehensive assistance with medical visa applications, travel arrangements, airport transfers, and comfortable accommodation for patients and their attendants.
  • Pre-treatment Virtual Consultations: Dr. Bahl is available for pre-treatment virtual consultations. This allows international patients to discuss their case, share medical records, and receive a preliminary opinion before travelling to India.

Frequently Asked Questions

Dr. Ankur Bahl is a Senior Medical Oncologist and Haematologist-Oncologist. He specialises in advanced treatments like Immunotherapy, Targeted Therapy, Hormonal Therapy, and Chemotherapy for a wide range of solid tumours and blood cancers.

Dr. Bahl has a rich and extensive experience of over 21 years in the field of oncology.

Dr. Bahl has vast experience in treating various cancers, including Head and Neck Cancer, Lung Cancer, Breast Cancer, Gastrointestinal Cancers, and haematological malignancies like Leukaemia and Lymphoma.

Dr. Bahl is considered a top medical oncologist in India due to his extensive experience, training at premier institutions like AIIMS, his pioneering research in targeted therapy, and his expertise in the latest cancer treatments. His patient-centric approach and contributions to oncology education further establish his reputation.

Dr. Bahl follows an evidence-based and patient-centric treatment approach. He focuses on creating personalised treatment plans using the latest technologies like Immunotherapy and Targeted Therapy to ensure the best clinical outcomes while maintaining the patient's quality of life.

Yes, Dr. Bahl regularly consults with international patients. The Cancer Rounds team provides complete assistance, including virtual consultations, visa help, and local logistics, to ensure a smooth experience.

Dr. Bahl was the lead author of the largest real-world study in India on the use of Cetuximab, a targeted therapy drug, in treating Head and Neck cancer. This study provided crucial data on the effectiveness and tolerance of the treatment in the Indian population.